Literature DB >> 8311852

Role of platelet-derived growth factor in glomerular disease.

R J Johnson1, J Floege, W G Couser, C E Alpers.   

Abstract

An approach for establishing a role for a growth factor in glomerular disease is presented. Using platelet-derived growth factor (PDGF) as an example, there is strong evidence to support the hypothesis that PDGF is a mediator of mesangial cell proliferation in glomerulonephritis. This includes evidence that (1) PDGF is a mitogen for mesangial cells in culture; (2) PDGF is expressed in both experimental and human glomerulonephritis in which mesangial cell proliferation occurs; (3) infusion of PDGF into rats induces mesangial cell proliferation and a hypercellular lesion; and (4) inhibition of PDGF in a model of experimental nephritis significantly reduces the mesangial cell proliferation. However, these data do not answer the question of whether or not the inhibition of PDGF in human diseases would be beneficial in the long term, because some cell proliferation is likely required for normal healing and repair. Further studies will be necessary to resolve this issue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8311852     DOI: 10.1681/ASN.V42119

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

1.  Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Barbara Tomaszewska; Anna Biernacka
Journal:  Pediatr Nephrol       Date:  2004-10-13       Impact factor: 3.714

2.  Ca2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells.

Authors:  H Ma; H Matsunaga; B Li; B Schieffer; M B Marrero; B N Ling
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 3.  Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease.

Authors:  K A Nath
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

4.  Platelet-derived growth factor-BB induces cystathionine γ-lyase expression in rat mesangial cells via a redox-dependent mechanism.

Authors:  Mohamed I Hassan; Meike Boosen; Liliana Schaefer; Jowita Kozlowska; Florian Eisel; Andreas von Knethen; Martina Beck; Ramadan A M Hemeida; Mohamed A M El-Moselhy; Farid M A Hamada; Karl-Friedrich Beck; Josef Pfeilschifter
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Creation of an In vivo cytosensor using engineered mesangial cells. Automatic sensing of glomerular inflammation controls transgene activity.

Authors:  M Kitamura; H Kawachi
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 6.  In vivo gene transfer, Koch's postulates, and renal disease.

Authors:  R J Johnson; D Lovett
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats.

Authors:  X Wu; M H Helfrich; M A Horton; L P Feigen; J B Lefkowith
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 8.  Mediation of immune glomerular injury.

Authors:  W G Couser
Journal:  Clin Investig       Date:  1993-10

9.  Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.

Authors:  Chen-Xing Zhang; Li Cai; Kang Shao; Jing Wu; Wei Zhou; Lan-Fang Cao; Tong-Xin Chen
Journal:  Pediatr Nephrol       Date:  2017-12-20       Impact factor: 3.714

10.  Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.

Authors:  D Ogawa; K Shikata; M Matsuda; S Okada; J Wada; S Yamaguchi; Y Suzuki; M Miyasaka; S Tojo; H Makino
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.